Jonas Valanciunas (Memphis Grizzlies) with a dunk vs the LA Clippers, 02/26/2021
Jonas Valanciunas (Memphis Grizzlies) with a dunk vs the LA Clippers, 02/26/2021
Israel marked its national Memorial Day for fallen soldiers on Wednesday, in a year when national attention has been focused on the plight of veterans suffering from psychological trauma. Memorial Day is the most solemn day on Israel's national calendar. Israel has fought half a dozen wars with neighboring Arab countries, battled two Palestinian uprisings and endured scores of deadly militant attacks since its establishment in 1948.
While exactly what she was trying to tell them is up for debate, many Taylor Swift fans agree she was trying to tell them something.
Sterling hit a one-week high against the dollar on Wednesday, recovering some ground after a brief dip the previous day following news the Bank of England's chief economist resigned. Haldane was widely seen as one of the more hawkish figures at the central bank, and had been the most upbeat member of the BoE's Monetary Policy Committee on prospects for a sharp economic recovery from the COVID-19 pandemic. By 0802 GMT, the pound was 0.2% higher on the day at $1.3786, having hit a one-week high of $1.38 against the dollar.
Iran's move to enrich uranium up to 60% purity is a response to the sabotage at its key nuclear facility, President Hassan Rouhani said on Wednesday, adding the Islamic Republic had no intention of building a nuclear weapon. After an explosion at its Natanz uranium enrichment site on Sunday blamed by Tehran on arch-foe Israel, Iran said it would begin enriching uranium at 60%, a move bringing the fissile material closer to levels suitable for a bomb.
Triglycerides, Esters, Mannitol, Sorbitol, Sucrose, Dextrose, Starch, Specialty Biopharmaceutical Excipients & Others. The biopharmaceuticals excipients market is expected to grow at a CAGR of 12.New York, April 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Biopharmaceuticals Excipients Market 2020-2030" - https://www.reportlinker.com/p06058472/?utm_source=GNW 2%. How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector. In this brand new 162-page report you will receive 85 charts– all unavailable elsewhere. The 162-page report provides clear detailed insight into the biopharmaceuticals excipients market. Discover the key drivers and challenges affecting the market. By ordering and reading our brand-new report today you stay better informed and ready to act. Report Scope • Biopharmaceuticals excipients market forecasts to 2030 • This report also breaks down the revenue forecast for the global pharmaceutical excipient market by product type (Solubilizers & Surfactants/Emulsifiers, Polyols, Carbohydrates, Speciality Biopharmaceutical Excipients) • Solubilizers & Surfactants/Emulsifiers: • Triglycerides • Esters • Others • This report also breaks down the revenue forecast for the biopharmaceuticals excipients market by Polyols: • Mannitol • Sorbitol • Others • This report also breaks down the revenue forecast for the biopharmaceuticals excipients market by carbohydrates: • Sucrose • Dextrose • Starch • Others • This report provides individual revenue forecasts to 2030 for these regional and national markets: • North America: US and Canada • Europe: UK, France, Germany, Spain, Italy, Rest of Europe • APAC: China, India, Australia, Indonesia, South Korea, Rest of APAC • MEA • RoW Each region is further broken down by product type • Our study gives a SWOT & PEST Analysis • Our study discusses the selected leading companies that are the major players in the biopharmaceuticals excipients market: • ABITEC Corp • Signet Chemical Corporation • Roquette Freres SA • Sigachi Industries • MEGGLE AG • & Other Companies This study is intended for anyone requiring commercial analyses for the biopharmaceuticals excipients market. You find data, trends, and predictions.Read the full report: https://www.reportlinker.com/p06058472/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
The victim was used as a replacement for another corpse, whose family wanted to avoid a burial ban.
MADRID — Spain’s prime minister says his government is maintaining its goal of immunizing 70% of the nation’s adult population, some 33 million people, by the end of the summer despite the delay in the European rollout of the Johnson & Johnson vaccine. Spain was expecting to receive 300,000 doses of the Janssen vaccine on Wednesday, the first delivery of the jab produced by Johnson & Johnson. The country wants to prioritize people aged between 70 and 79 to receive the single-dose vaccine. But those plans had to be put on hold after the pharmaceutical company delayed delivery of the vaccine to European countries following the decision by the U.S. Food and Drug Administration to pause the shots in the United States to investigate possible links to very rare blood clots. The hold up comes after various delays in shipments of other vaccines and a similar blood clot scare with the AstraZeneca vaccine that led Spain to limit it to people over 60 years old. Prime Minister Pedro Sánchez, however, told Spain’s Parliament on Wednesday that “the pace of vaccination is going to accelerate in the month of April and (…) we will meet out goal.” ___ THE VIRUS OUTBREAK: — US recommends ‘pause’ for J&J shots in blow to vaccine drive — Biden says pause on J&J shots shows gov’t putting safety 1st — EXPLAINER: What’s known about COVID vaccines and rare clots — The postponed Tokyo Olympics open in 100 days, but nothing is certain these days — California is lagging in reopening schools, and parents are finding some options unacceptable — Follow AP’s pandemic coverage at https://apnews.com/hub/coronavirus-pandemic and https://apnews.com/hub/coronavirus-vaccine ___ HERE’S WHAT ELSE IS HAPPENING: BERLIN — German health authorities are recommending that people younger than 60 who have already received one shot of the AstraZeneca vaccine use a different vaccine for their second dose over concerns of blood clots. The Health Ministry said Wednesday that it was recommending that people in that category receive as their second shot either the Pfizer/BioNTech or Moderna vaccination, both of which were developed using a different process. It says, however, that in individual cases younger people wanting a second AstraZeneca shot can get one so long as they have a careful medical risk assessment. That also applies to high-risk people under the age of 60 still awaiting their primary vaccination. The reports of rare blood clots in some people who’ve received the vaccine prompted Germany and several other countries in the 27-nation European Union to limit the AstraZeneca shots to older age groups, who are more at risk from serious illness when infected with COVID-19. ____ CANBERRA, Australia — Australia’s trade minister will fly to Europe to argue against export restrictions on COVID-19 vaccines as the nation attempts to accelerate its inoculation rollout. Trade Minister Dan Tehan leaves on Thursday for Geneva, Berlin, Brussels, Paris and London with vaccine supply added to a post-Brexit trade deal agenda. “The first idea I’ll be bringing to the table is that export restrictions aren’t the way to go,” Tehan told Australian Broadcasting Corp. on Wednesday. Deliveries of the AstraZeneca vaccine to Australia were 3 million doses behind schedule, he said. Australia is rethinking its vaccine rollout after the nation's health authorities advised last week that Pfizer was now the preferred option for people younger than 50 because of a potential risk of rare blood clots linked to the AstraZeneca shot. The government also abandoned its target of delivering at least one dose of either vaccine to all eligible adults among a population of 26 million by October. But Prime Minister Scott Morrison said on Wednesday offering all Australian adults at least one vaccine dose by the end of 2021 was a possibility if international supply lines remained open. The European Union last month blocked a shipment of more than 250,000 AstraZeneca doses from Italy to Australia because the need for them was not considered great enough in a country largely successful in containing the coronavirus. ___ SEOUL, South Korea — South Korea has recorded its highest daily jump in new COVID-19 infections in about three months, as officials urge the public to maintain vigilance. The Korea Disease Control and Prevention Agency said Wednesday it’s confirmed 731 new cases over the past 24 hours. They brought the country’s total to 111,419 with 1,782 deaths. The spike comes amid criticism of a slow vaccine rollout while people are increasingly venturing outdoors to take advantage of good weather. Senior health official Yoon Taeho says an increased mobility last weekend was proof that South Korea’s public vigilance has loosened, and that elevating social distancing rules will be discussed in the next few days. ___ HELENA, Mont. — Montana Gov. Greg Gianforte has issued an executive order banning the development or use of vaccine passports in Montana. Vaccine passports are documents that could be used to verify coronavirus immunization status and allow inoculated people to more freely travel, shop and dine. The move by Gianforte on Tuesday comes as vaccine passports have drawn criticism as a heavy-handed intrusion into personal freedom and private health choices. Gianforte says in a statement that he encourages all Montana residents to get vaccinated but that it is “entirely voluntary.” Vaccine passports have been implemented in New York but the White House has said there will not be any federal vaccine passport program. ___ HOLLAND, Mich. — A western Michigan restaurant owner who spent four nights in jail for violating coronavirus-related orders is firing back weeks later with a demand that $15,000 in fines be refunded and contempt findings dropped. An attorney for Marlena Pavlos-Hackney said her rights were violated during a contentious court hearing on March 19. State regulators yanked Pavlos-Hackney’s food license in January for serving indoor diners and breaking other rules related to preventing the spread of COVID-19. But the restaurant, Marlena’s Bistro and Pizzeria in Holland, stayed open in defiance. Pavlos-Hackney refused to turn herself in to face a contempt hearing. She was arrested and spent four nights in jail until authorities were convinced that her restaurant would stay closed. Attorney Robert Baker, who wasn’t hired until Pavlos-Hackney was arrested, said a judge questioned her without recognizing that she had a lawyer. He said there was “no testing of any evidence” or an opportunity to cross-examine or produce witnesses. A message seeking comment was sent to the attorney general’s office. ___ AMSTERDAM — The Dutch government has presented a roadmap for relaxing coronavirus lockdown measures, but caretaker Prime Minister Mark Rutte is stressing that it is still too early to ease restrictions. In a nationally televised press conference Tuesday, Rutte said hospitals in the Netherlands are as crowded with COVID-19 patients now as they were during the first wave of the pandemic last year and that it would be irresponsible to relax the country’s months-long lockdown now. The government had previously said it hoped the first relaxation could have started April 21, but Rutte said that was too soon. Earlier Tuesday, the Dutch public health institute said the number of new coronavirus infections rose 6% over the past week to 51,240, with the largest increase in positive tests recorded among children aged 13-17 years. The increase comes despite the months-long tough lockdown in the Netherlands including a nighttime curfew, closed bars and restaurants and shuttered public institutions like museums and zoos. ___ WASHINGTON — U.S. health insurance customers may receive higher premium rebates than normal later this year partly because insurers had less care to cover after COVID-19 arrived in 2020. Some individual insurance customers could receive premium credits or rebates of nearly $300 on average, according to an analysis of government data from the non-profit Kaiser Family Foundation. The Affordable Care Act requires insurers to give customers refunds or premium credits if they don’t spend certain percentages of the premiums they collect on care and costs related to it. Kaiser’s analysis noted that last year hospitals and other care providers cancelled surgeries and non-essential care early in the pandemic and then during subsequent COVID-19 spikes. Kaiser Vice-President Cynthia Cox said nearly half of customers in the individual market receive these annual rebates. Some people with employer-sponsored coverage also may get rebates that they share with their company. Rebate totals will be finalized later this year. They generally are then delivered by the end of September. The totals will vary by market and depend on factors like whether an insurer has already offered premium breaks to counter the drop in care. ___ WASHINGTON — The nation’s capital city joined a growing list of states in suspending the Johnson & Johnson COVID-19 vaccine that’s become the focus of a federal examination of rare blood clots. District of Columbia health director Dr. LaQuandra Nesbitt says she’s not aware of any cases of dangerous blood clots among the 16,000 Washingtonians who had received the J&J one-dose vaccine before the temporary halt recommended by federal health authorities. “This pause means that the system is working properly,” Nesbitt says. Dr. Anthony Fauci, the nation’s top infectious disease expert, echoed Nesbitt, saying Americans who’ve recently received a Johnson & Johnson COVID-19 vaccine shouldn’t be anxious about the pause. Fauci called it a “testimony to how seriously we take safety.” J&J said in a statement Tuesday it was aware of the reports of blood clots, but that no link to its vaccine had been established. A CDC committee will meet Wednesday to discuss the cases. The FDA has launched an investigation into the cause of the clots and low platelet counts. There have been six reported clots among the 6.8 million shots administered. U.S. health authorities cautioned doctors against using a typical clot treatment, the blood-thinner heparin. “In this setting, administration of heparin may be dangerous and alternative treatments need to be given,” the FDA and CDC say. Washington state, Idaho, California, Alabama, Wisconsin, Colorado, Nevada and Alaska are among the states that have temporarily halted or have recommended pausing the use of the Johnson & Johnson shot amid the investigation. ___ BERLIN — South Africa has suspended giving the Johnson & Johnson vaccine as a “precautionary measure” following the FDA decision in the U.S. to pause the use of the vaccine while rare blood clots are examined. All six cases were in women between ages 18 to 48, including one who died. The unusual clots occurred six to 13 days after vaccination. South Africa has given more than 289,000 shots of the J&J vaccine to the country’s health workers without any reports of blood clots, Health Minister Dr. Zweli Mkhize says. He says South Africa is halting the use of the J&J doses “out of an abundance of caution.” He expects the questions regarding the J&J vaccine should “be cleared within a matter of days.” Recently, the blood clot reports prompted several European Union countries in the 27-nation bloc to limit the AstraZeneca vaccine to older age groups. The Associated Press
Virgin Media and O2 merger cleared by competition watchdogThe £31bn 50-50 joint venture will create new ‘national champion’ to challenge BT O2 has 34 million mobile customers, while Virgin Media has 5.3 million broadband, pay-TV and mobile users. Photograph: Andre M Chang/Zuma Wire/Rex/Shutterstock
Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Global Virtual Events Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Global Virtual Events Market 2021-2025The virtual events market is poised to grow by $269.20 bn during 2021-2025 progressing at a CAGR of 33% during the forecast period. The market is driven by the rise in number of corporate events and increasing need to improve competitive responsiveness. The report on virtual events market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The virtual events market analysis includes application segment and geographical landscapes. This study identifies the growing prominence of social networking sites as one of the prime reasons driving the virtual events market growth during the next few years. The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading virtual events market vendors that include Adobe Inc., Avaya Holdings Corp., Aventri Inc., Cisco Systems Inc., Cvent Inc., Huawei Investment & Holding Co. Ltd., International Business Machines Corp., Microsoft Corp., Ungerboeck, and Zoom Video Communications Inc.. Also, the virtual events market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.Key Topics Covered: Executive Summary Market Overview Market Landscape Market ecosystemMarket characteristicsValue chain analysis Market Sizing Market definitionMarket segment analysisMarket size 2020Market outlook: Forecast for 2020 - 2025 Five Forces Analysis Bargaining power of buyersBargaining power of suppliersThreat of new entrantsThreat of substitutesThreat of rivalryMarket condition Market Segmentation by Application Market segmentsComparison by ApplicationUC and C and video conferencing - Market size and forecast 2020-2025Web conferencing - Market size and forecast 2020-2025Market opportunity by Application Market segmentation by end-users Virtual events for educational institutionsVirtual events for trade showsVirtual events for enterprises Customer landscapeGeographic Landscape Geographic segmentationGeographic comparisonNorth America - Market size and forecast 2020-2025APAC - Market size and forecast 2020-2025Europe - Market size and forecast 2020-2025MEA - Market size and forecast 2020-2025South America - Market size and forecast 2020-2025Key leading countriesMarket opportunity by geographyMarket driversMarket challengesMarket trends Vendor Landscape Vendor landscapeLandscape disruptionCompetitive scenario Vendor Analysis Vendors coveredMarket positioning of vendorsAdobe Inc.Avaya Holdings Corp.Aventri Inc.Cisco Systems Inc.Cvent Inc.Huawei Investment & Holding Co. Ltd.International Business Machines Corp.Microsoft Corp.UngerboeckZoom Video Communications Inc. AppendixFor more information about this report visit https://www.researchandmarkets.com/r/tmbf4b CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The 2014 student abductions led to a plan backed by the UK but little has come of it seven years on.
Kristina Keneally accuses Peter Dutton of cancelling her trip to meet Biloela family. Labor senator says she received Border Force permission for the Christmas Island meeting at 4.50pm but defence minister ‘cancelled the trip’ at 5.12pm
Protests continue after a Minnesota police chief and the officer who killed a black motorist quit.
Vaccine rollouts are brightening the outlook for global oil demand, the International Energy Agency (IEA) said on Wednesday, though rising cases in some major oil-consuming countries show a recovery may be fragile. "Fundamentals look decidedly stronger," the IEA said in its monthly report. "The massive overhang in global oil inventories that built up during last year's COVID-19 demand shock is being worked off, vaccine campaigns are gathering pace and the global economy appears to be on a better footing."
This comes a day after more than three million Hindus visited the festival as India's cases soar.
As Britain starts to open up, Ramadan begins. It feels like perfect timing. Lockdown made us think about the big questions – and a holy month is a welcome antidote to the return of consumerism
(Bloomberg) -- The European Union is poised to ban artificial intelligence systems used for mass surveillance or for ranking social behavior, while companies developing AI could face fines as high as 4% of global revenue if they fail to comply with new rules governing the software applications.The rules are part of legislation set to be proposed by the European Commission, the bloc’s executive body, according to a draft of the proposal obtained by Bloomberg. The details could change before the commission unveils the measure, which is expected to be as soon as next week.The EU proposal is expected to include the following rules:AI systems used to manipulate human behavior, exploit information about individuals or groups of individuals, used to carry out social scoring or for indiscriminate surveillance would all be banned in the EU. Some public security exceptions would apply.Remote biometric identification systems used in public places, like facial recognition, would need special authorization from authorities.AI applications considered to be ‘high-risk’ would have to undergo inspections before deployment to ensure systems are trained on unbiased data sets, in a traceable way and with human oversight.High-risk AI would pertain to systems that could endanger people’s safety, lives or fundamental rights, as well as the EU’s democratic processes -- such as self-driving cars and remote surgery, among others.Some companies will be allowed to undertake assessments themselves, whereas others will be subject to checks by third-parties. Compliance certificates issued by assessment bodies will be valid for up to five years.Rules would apply equally to companies based in the EU or abroad.European member states would be required to appoint assessment bodies to test, certify and inspect the systems, according to the document. Companies that develop prohibited AI services, or supply incorrect information or fail to cooperate with the national authorities could be fined up to 4% of global revenue.The rules won’t apply to AI systems used exclusively for military purposes, according to the document.A European Commission spokesman declined to comment on the proposed rules. Politico reported on the draft document earlier.“It’s important for us at a European level to pass a very strong message and set the standards in terms of how far these technologies should be allowed to go,” Dragos Tudorache, a liberal member of the European Parliament and head of the committee on artificial intelligence, said in an interview. “Putting a regulatory framework around them is a must and it’s good that the European Commission takes this direction.”As artificial intelligence has started to penetrate every part of society, from shopping suggestions and voice assistants to decisions around hiring, insurance and law enforcement, the EU wants to ensure technology deployed in Europe is transparent, has human oversight and meets its high standards for user privacy.The proposed rules come as the EU tries to catch up to the U.S. and China on the roll-out of artificial intelligence and other advanced technology. The new requirements could hinder tech firms in the region from competing with foreign rivals if they are delayed in unveiling products because they first have to be tested.Once proposed by the commission, the rules could still change following input from the European Parliament and the bloc’s member states before becoming law.Tudorache said it was critical that the final version of law doesn’t stifle innovation and limits bureaucratic hurdles as much as possible.“We have to be very, very clear in the way we regulate - when, where and in which conditions, engineers and businesses have to actually go to regulators to seek authorization and to be very clear where it’s not,” he said.(Updates with reaction from MEP in 12th, 16th paragraphs)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
The supermarket giant said profits were weighed down by £892 million in coronavirus-related costs.
Fishmongers’ Hall attacker Usman Khan claimed he had turned away from “the wrong path” just minutes before launching his stabbing rampage, an inquest has heard. The 28-year-old was one of the attendees at a Learning Together event on November 29, 2019, when he stabbed to death Jack Merritt and Saskia Jones inside the historic City of London hall. Khan had been part of a group of extremists who were convicted in 2012 of plotting an attack on the London Stock Exchange, but he had been freed from prison shortly before carrying out the atrocity at Fishmongers Hall.
Four-month-old Margaret had stayed inside the giraffe house at Whipsnade Zoo with mother Luna until this week.
Significant differences remain between the UK and European Union over the implementation of the Northern Ireland Protocol.